Shares of vaccine stocks are trading lower, not seeing sector-specific catalyst from the session. Investors continue to weigh sector outlook going into 2022 as well as omicron uncertainty, with the sector pulling back following 2021 strength

Never miss a trade again with the fastest news alerts in the world!

This headline only article is a sample of real-time intelligence Benzinga Pro traders use to win in the markets everyday.

Want the fastest, most accurate stock market intelligence? Want EXCLUSIVE stories originated by Benzinga reporters? Join 10,000+ serious traders in the Benzinga Pro community!